Search

Rockeby to acquire bird flu rapid tests globally

West Perth-based biotechnology company Rockeby Biomed Ltd has signed a Memorandum of Understanding with Pacific Biotech, whereby Pacific will assign the ownership of the avian and human influenza rapid diagnostic tests to Rockeby .

The company said the change from the previous marketing agreement to a full rights agreement would result in a reduction in the direct cost of both products of approximately 70 per cent.

Rockeby said the reduction would give the company a competitive edge in the market, and improve the long-term financial return to Rockeby.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Register for free

Sign up here for free access to 8 articles per month + twice daily business email alerts.

CAPTCHA
Thanks! This question prevents spammers...
Image CAPTCHA
Enter the characters shown in the image.

Add your comment

Share Price

Closing price for the last 90 trading days
Source: Morningstar

BN30 Index

Index = 100 as of 4 Jan 2016
Source: Morningstar

Total Shareholder Return as at 31/08/16

1 year TSR5 year TSR
112thFortescue Metals Group162%-2%
316thSouth3226%0%
534thWoodside Petroleum-8%1%
543rdIluka Resources-9%-14%
718thAtlas Iron-58%-68%
777 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

20/09/16
$0 Issued
07/09/16
$0 Other
07/09/16
$0 Bought
Total value as at the date of the transaction
Source: Morningstar

Revenue

1st-Fortescue Metals Group$9,806.1m
2nd↑South32$8,262.9m
3rd-Woodside Petroleum$6,935.4m
4th↑Iluka Resources$884.1m
5th↑Atlas Iron$803.7m
526 listed resources companies ranked by revenue.
Source: Morningstar

Remuneration from Fortescue Metals Group

3rdNev Power$5.992m
12thStephen Pearce$2.551m
25thNick Cernotta$1.566m
Ranked by total remuneration from all listed WA companies

BNiQ Disclaimer